ReShape Lifesciences amends asset purchase deal; price cut to $2.25M, deadline to June 30

Vyome Holdings, Inc

Exercise price under Asset Purchase Agreement reduced from $5.16M to $2.25M.
Termination date extended from March 31, 2025 to June 30, 2025.
Amendment dated April 25, 2025, between ReShape and Ninjour Health International Limited.
Original Asset Purchase Agreement was entered into on July 8, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.